Correlation Between Dupont De and BriaCell Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dupont De and BriaCell Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dupont De and BriaCell Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dupont De Nemours and BriaCell Therapeutics Corp, you can compare the effects of market volatilities on Dupont De and BriaCell Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dupont De with a short position of BriaCell Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dupont De and BriaCell Therapeutics.

Diversification Opportunities for Dupont De and BriaCell Therapeutics

0.5
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Dupont and BriaCell is 0.5. Overlapping area represents the amount of risk that can be diversified away by holding Dupont De Nemours and BriaCell Therapeutics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BriaCell Therapeutics and Dupont De is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dupont De Nemours are associated (or correlated) with BriaCell Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BriaCell Therapeutics has no effect on the direction of Dupont De i.e., Dupont De and BriaCell Therapeutics go up and down completely randomly.

Pair Corralation between Dupont De and BriaCell Therapeutics

Allowing for the 90-day total investment horizon Dupont De Nemours is expected to generate 0.19 times more return on investment than BriaCell Therapeutics. However, Dupont De Nemours is 5.28 times less risky than BriaCell Therapeutics. It trades about 0.04 of its potential returns per unit of risk. BriaCell Therapeutics Corp is currently generating about 0.0 per unit of risk. If you would invest  6,655  in Dupont De Nemours on August 30, 2024 and sell it today you would earn a total of  1,735  from holding Dupont De Nemours or generate 26.07% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy99.19%
ValuesDaily Returns

Dupont De Nemours  vs.  BriaCell Therapeutics Corp

 Performance 
       Timeline  
Dupont De Nemours 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Weak
Over the last 90 days Dupont De Nemours has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound fundamental indicators, Dupont De is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.
BriaCell Therapeutics 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in BriaCell Therapeutics Corp are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile basic indicators, BriaCell Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Dupont De and BriaCell Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Dupont De and BriaCell Therapeutics

The main advantage of trading using opposite Dupont De and BriaCell Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dupont De position performs unexpectedly, BriaCell Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BriaCell Therapeutics will offset losses from the drop in BriaCell Therapeutics' long position.
The idea behind Dupont De Nemours and BriaCell Therapeutics Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Complementary Tools

Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Stocks Directory
Find actively traded stocks across global markets
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas